Specialty Hospitals Industry in India

Specialty hospitals in India provide focused care through providers built around defined patient needs and clinical capabilities.

Top specialty hospitals companies in India (listed and private)

Frequently asked questions

How large is the specialty hospitals industry in India?

1989 specialty hospitals companies with statutory filings (10 listed, 1979 private) reported combined revenue of ₹2.47 lakh crore in FY2025, +12.8% on the same companies, and aggregate EBITDA of ₹43,622 crore. As filed each year, combined revenue was ₹77,703 crore in FY2018, reached ₹2.47 lakh crore in FY2025, the highest in the period; year-on-year changes are measured on the same companies. The 8 listed companies with an exchange price are worth ₹1.08 lakh crore in market capitalisation. Size here is measured in revenue, profit and market value, from statutory filings and exchange prices, not in physical volume of output.

Is profitability improving or deteriorating?

Mixed. The aggregate EBITDA margin of specialty hospitals companies was 17.6% in FY2025, 0.5 pts above FY2024, against a peak of 18.6% in FY2021. The low since the peak was 15.9% in FY2023. Profit after tax margin was 8.9% (+3.2 pts on FY2024). Aggregate EBITDA of listed and private specialty hospitals companies moved +40% from FY2022 to FY2025 on a same-company basis; FY2025 EBITDA was ₹43,622 crore (+11.2% on FY2024).

Which companies are leading the specialty hospitals industry?

By FY2025 revenue the largest specialty hospitals companies are Karnataka Power Corporation (₹12,605 crore, 39.3% EBITDA margin, private); Intel Technology India (₹12,120 crore, 21.0% EBITDA margin, private); Abbott Healthcare (₹8,686 crore, 20.6% EBITDA margin, private); Manipal Health Enterprises (₹8,242 crore, 27.3% EBITDA margin, private); Wipro Ge Healthcare (₹8,075 crore, 14.2% EBITDA margin, private). Among the ten largest, Karnataka Power Corporation (39.3%) and Manipal Health Enterprises (27.3%) earn the widest EBITDA margins and Ashirvad Pipes (6.9%) the thinnest. 23 of the 25 largest are private companies, which a listed-only view leaves out.

Where is demand or investment changing?

In the news: Digital health carried 2.4% of specialty hospitals stories in 2025-06 to 2026-05, up 0.9 pts (+58%) on the prior 12 months; net tone +88 vs +12 for all specialty hospitals stories. In buyer searches: Search interest in hospital services queries (hospital near me, private hospital, speciality hospital) was +15% in the 12 months to 2026-09 vs the prior 12, led by “private hospital” (+40%), followed by clinic services (-2%); clinic services moved -2%.

What should I investigate next?

These are the findings that fired on the data, negative signals first, each with the topic that holds the evidence: Specialty Hospitals EBITDA grew 40% since FY2022 (Industry financials). 43 private specialty hospitals providers pass an IPO-readiness screen (Top specialty hospitals companies in India). Digital health is gaining the most ground in specialty hospitals news (Specialty Hospitals in the news). Hospital services searches rose most in the last year (Search & demand signals). Median EV/EBITDA is 35.6× and median P/E 39.5× across 8 priced specialty hospitals companies. (Market capitalisation & valuation).

How are specialty hospitals stocks valued?

The median trailing P/E is 39.5× and the median EV/EBITDA 35.6× across 8 priced companies.

What defines the specialty hospitals industry?

It includes providers whose care model is organised around focused clinical services and patient pathways.

What matters when assessing specialty hospital providers?

Care quality, operating capacity, patient access, clinician depth and the durability of the provider model are central considerations.

Research information, not investment advice.